{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:25:55Z","timestamp":1785929155557,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.apsb.2024.02.026","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T15:37:16Z","timestamp":1709480236000},"page":"3125-3139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Glycnsisitin A: A promising bicyclic peptide against heart failure that facilitates TFRC-mediated uptake of iron in cardiomyocytes"],"prefix":"10.1016","volume":"14","author":[{"given":"Jichao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.02.026_bib1","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2024.02.026_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(17)32873-8","article-title":"Rising incidence of heart failure demands action","volume":"391","author":"Zannad","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.02.026_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"Mcdonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.apsb.2024.02.026_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-022-00972-6","article-title":"Signaling cascades in the failing heart and emerging therapeutic strategies","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct Tar"},{"key":"10.1016\/j.apsb.2024.02.026_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"391","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.02.026_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","article-title":"Iron deficiency and cardiovascular disease","volume":"44","author":"Savarese","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2024.02.026_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40001-022-00922-6","article-title":"How to diagnose iron deficiency in chronic disease: a review of current methods and potential marker for the outcome","volume":"28","author":"Rohr","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.apsb.2024.02.026_bib8","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.02.026_bib9","doi-asserted-by":"crossref","first-page":"JC40","DOI":"10.7326\/J23-0012","article-title":"In HF with iron deficiency, IV ferric derisomaltose was associated with lower rates of HF hospitalization or CV death","volume":"176","author":"Lerman","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.apsb.2024.02.026_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116320","article-title":"The protective effects of Zhi-Gan-Cao-Tang against diabetic myocardial infarction injury and identification of its effective constituents","volume":"309","author":"Hu","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.apsb.2024.02.026_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jnatprod.5b00877","article-title":"Bioactive constituents of Glycyrrhiza uralensis (Licorice): discovery of the effective components of a traditional herbal medicine","volume":"79","author":"Ji","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2024.02.026_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1021\/jf404939f","article-title":"Bioactivity and potential health benefits of licorice","volume":"62","author":"Kao","year":"2014","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.apsb.2024.02.026_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115686","article-title":"Chemical analysis of the Chinese herbal medicine licorice (Gan-Cao): an update review","volume":"299","author":"Shang","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.apsb.2024.02.026_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41589-021-00892-6","article-title":"Discovery and biosynthesis of cyclic plant peptides via autocatalytic cyclases","volume":"18","author":"Chigumba","year":"2022","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2024.02.026_bib15","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1093\/eurheartj\/ehy600","article-title":"Treatments targeting inotropy","volume":"40","author":"Maack","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2024.02.026_bib16","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(18)31808-7","article-title":"Heart failure drug treatment","volume":"393","author":"Rossignol","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.02.026_bib17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.amjmed.2021.05.007","article-title":"Polypharmacy in heart failure: progress but also problem","volume":"134","author":"Goyal","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.apsb.2024.02.026_bib18","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/ehf2.13265","article-title":"Iron deficiency in heart failure","volume":"8","author":"Loncar","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.apsb.2024.02.026_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2024.02.026_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1021\/cr040699h","article-title":"Plant cyclopeptides","volume":"106","author":"Tan","year":"2006","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.02.026_bib21","doi-asserted-by":"crossref","first-page":"12690","DOI":"10.1002\/chem.201702117","article-title":"Bicyclic peptides as next-generation therapeutics","volume":"23","author":"Rhodes","year":"2017","journal-title":"Chem Eur J"},{"key":"10.1016\/j.apsb.2024.02.026_bib22","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","article-title":"Intravenous iron alone for the treatment of anemia in patients with chronic heart failure","volume":"48","author":"Bolger","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.apsb.2024.02.026_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ehf2.13753","article-title":"Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction","volume":"9","author":"L\u00f3pez-vilella","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.apsb.2024.02.026_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2024.02.026_bib25","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1113\/JP279376","article-title":"The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction","volume":"599","author":"Federico","year":"2021","journal-title":"J Physiol"},{"key":"10.1016\/j.apsb.2024.02.026_bib26","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2020.10.007","article-title":"Energy metabolism disorders and potential therapeutic drugs in heart failure","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.02.026_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.apsb.2024.02.026_bib28","first-page":"17","article-title":"Doxorubicin induced heart failure: phenotype and molecular mechanisms","volume":"10","author":"Mitry","year":"2016","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.apsb.2024.02.026_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113903","article-title":"Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy","volume":"156","author":"Chen","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2024.02.026_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.pmbts.2022.06.019","article-title":"Regulation of transferrin receptor trafficking by optineurin and its disease-associated mutants","volume":"194","author":"Moharir","year":"2023","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.apsb.2024.02.026_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","article-title":"Lethal cardiomyopathy in mice lacking transferrin receptor in the heart","volume":"13","author":"Xu","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2024.02.026_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T03:10:09Z","timestamp":1720581009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2211383524000790"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.02.026","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycnsisitin A: A promising bicyclic peptide against heart failure that facilitates TFRC-mediated uptake of iron in cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}